Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.60
0.57%
Copper
4.13
(0.47%)
Oil
69.97
1.35%
Bitcoin
97,539.65
3.38%
FTSE 100
8,116.62
0.39%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.28%
Hang Seng
19,601.11
(0.23%)

Nova EYE Medical Ltd

EYE

ASX

Nova Eye Medical Limited (EYE) is into design, development, manufacture, marketing and sales of surgical devices for the treatment of glaucoma, a leading cause of blindness. In addition, the Company is engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser, 2RT, for the treatment of retinal disease via the AlphaRET segment.

Latest Posts

Line Chart with Gradient
Price
$0.000
-0.005 (-3.13%)
At Close (AEST)
Related Companies
IMRICOR MEDICAL SYSTEMS INC.
$IMR
CURVEBEAM AI LIMITED
$CVB
COCHLEAR LIMITED
$COH
RAMSAY HEALTH CARE LIMITED
$RHC
NEXT SCIENCE LIMITED
$NXS

Leave a Comment on EYE


Comments for EYE

    Latest Posts

    nova-eye-medical-asx-eye-reports-significant-financial-growth-in-q1-fy24-eye
    Health Care $EYE
    Nova Eye Medical (ASX: $EYE) reports significant financial growth in Q1 FY24Achieves 32% increase in global sales, driven by strong demand in key markets including USA and China
    October 31, 2024
    nova-eye-medical-asx-eye-reports-record-usa-sales-for-february-2024-eye
    Health Care $EYE

    Nova Eye Medical (ASX: $EYE) reports record usa sales for february 2024

    USA sales reach US$0.99 million, representing 20% growth from January 2024

    March 5, 2024
    nova-eye-medical-asx-eye-conducts-underwritten-entitlement-offer-eye
    Health Care $EYE

    Nova Eye Medical (ASX: $EYE) conducts underwritten entitlement offer

    Capital raising to capitalize on growth opportunities in glaucoma market

    February 19, 2024
    nova-eye-medical-asx-eye-addresses-glaucoma-and-amd-opportunities-eye
    Health Care $EYE

    Nova Eye Medical (ASX: $EYE) addresses glaucoma and AMD opportunities

    Company presents strong sales in FY23 and challenges in USA Medicare changes

    January 14, 2024
    nova-eye-medical-asx-eye-defers-ngs-medicare-changes-eye
    Health Care $EYE

    Nova Eye Medical (ASX: $EYE) defers NGS Medicare changes

    NGS defers local reimbursement coverage for MIGS procedures to March 23, 2024

    January 12, 2024
    nova-eye-medical-asxeye-defers-ngs-medicare-changes-eye
    Health Care $EYE

    Nova Eye Medical (ASX:$EYE) defers NGS Medicare changes

    NGS defers local reimbursement coverage for MIGS procedures to March 23, 2024

    November 30, 2023
    nova-eye-medical-asxeye-addresses-glaucoma-and-amd-opportunities-eye
    Health Care $EYE

    Nova Eye Medical (ASX:$EYE) addresses glaucoma and AMD opportunities

    Company presents strong sales in FY23 and challenges in USA Medicare changes

    November 27, 2023

    EYE

    $EYE

    Nova Eye Medical (ASX: $EYE) reports significant financial growth in Q1 FY24

    Achieves 32% increase in global sales, driven by strong demand in key markets including USA and China

    EYE

    $EYE

    Nova Eye Medical (ASX: $EYE) reports record usa sales for february 2024

    USA sales reach US$0.99 million, representing 20% growth from January 2024

    EYE

    $EYE

    Nova Eye Medical (ASX: $EYE) conducts underwritten entitlement offer

    Capital raising to capitalize on growth opportunities in glaucoma market

    EYE

    $EYE

    Nova Eye Medical (ASX: $EYE) addresses glaucoma and AMD opportunities

    Company presents strong sales in FY23 and challenges in USA Medicare changes

    EYE

    $EYE

    Nova Eye Medical (ASX: $EYE) defers NGS Medicare changes

    NGS defers local reimbursement coverage for MIGS procedures to March 23, 2024

    EYE

    $EYE

    Nova Eye Medical (ASX:$EYE) defers NGS Medicare changes

    NGS defers local reimbursement coverage for MIGS procedures to March 23, 2024

    EYE

    $EYE

    Nova Eye Medical (ASX:$EYE) addresses glaucoma and AMD opportunities

    Company presents strong sales in FY23 and challenges in USA Medicare changes

    Related Companies
    RESMED INC
    $RMD
    CARETEQ LIMITED
    $CTQ
    ADHERIUM LIMITED
    $ADR
    COCHLEAR LIMITED
    $COH
    HEALIUS LIMITED
    $HLS

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions